These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23796652)

  • 1. Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion.
    Kang LY; Mok KT; Liu SI; Tsai CC; Wang BW; Chen IS; Chen YC; Chang BM; Chou NH
    J Chin Med Assoc; 2013 Aug; 76(8):425-31. PubMed ID: 23796652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
    Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
    BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
    Scaringi S; Kianmanesh R; Sabate JM; Facchiano E; Jouet P; Coffin B; Parmentier G; Hay JM; Flamant Y; Msika S
    Eur J Surg Oncol; 2008 Nov; 34(11):1246-52. PubMed ID: 18222622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases.
    Bălescu I; Godoroja D; Gongu M; Tomulescu V; Copăescu C
    Chirurgia (Bucur); 2017; 112(6):714-725. PubMed ID: 29288614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of neoadjuvant chemotherapy combined with prophylactic intraperitoneal hyperthermic chemotherapy for patients diagnosed with clinical T4 gastric cancer who underwent laparoscopic radical gastrectomy: a retrospective cohort study based on propensity score matching.
    Lv CB; Tong LY; Zeng WM; Chen QX; Fang SY; Sun YQ; Cai LS
    World J Surg Oncol; 2024 Sep; 22(1):244. PubMed ID: 39256787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity-score matched analysis.
    Diniz TP; da Costa WL; Fonseca de Jesus VH; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Torres SM; Felismino TC; Coimbra FJF
    J Surg Oncol; 2020 Apr; 121(5):823-832. PubMed ID: 31950511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) associated with curative surgery for locally advanced gastric carcinoma. An initial experience.
    De Roover A; Detroz B; Detry O; Coimbra C; Polus M; Belaiche J; Meurisse M; Honoré P
    Acta Chir Belg; 2006; 106(3):297-301. PubMed ID: 16910002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
    Desiderio J; Chao J; Melstrom L; Warner S; Tozzi F; Fong Y; Parisi A; Woo Y
    Eur J Cancer; 2017 Jul; 79():1-14. PubMed ID: 28456089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic intraperitoneal chemoperfusion in combined treatment of locally advanced and disseminated gastric cancer: results of a single-centre retrospective study.
    Yarema RR; Ohorchak MA; Zubarev GP; Mylyan YP; Oliynyk YY; Zubarev MG; Gyrya PI; Kovalchuk YJ; Safiyan VI; Fetsych TG
    Int J Hyperthermia; 2014 May; 30(3):159-65. PubMed ID: 24641798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study.
    Beeharry MK; Zhu ZL; Liu WT; Yao XX; Yan M; Zhu ZG
    BMC Cancer; 2019 Sep; 19(1):932. PubMed ID: 31533660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative treatment of the advanced gastric cancer by means of surgery and HIPEC.
    Hoskovec D; Varga J; Antos F; Kaspar M; Vitek P; Benkova K; Dytrych P; Konecna E
    Bratisl Lek Listy; 2013; 114(12):735-9. PubMed ID: 24329514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermic intraperitoneal chemotherapy in serosa-invasive gastric cancer patients.
    Reutovich MY; Krasko OV; Sukonko OG
    Eur J Surg Oncol; 2019 Dec; 45(12):2405-2411. PubMed ID: 31387756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma.
    Fujimoto S; Takahashi M; Mutou T; Kobayashi K; Toyosawa T
    Cancer; 1999 Feb; 85(3):529-34. PubMed ID: 10091726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery.
    Fan B; Bu Z; Zhang J; Zong X; Ji X; Fu T; Jia Z; Zhang Y; Wu X
    BMC Cancer; 2021 Mar; 21(1):216. PubMed ID: 33653317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
    Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
    Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
    Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
    J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.
    Klaver CE; Musters GD; Bemelman WA; Punt CJ; Verwaal VJ; Dijkgraaf MG; Aalbers AG; van der Bilt JD; Boerma D; Bremers AJ; Burger JW; Buskens CJ; Evers P; van Ginkel RJ; van Grevenstein WM; Hemmer PH; de Hingh IH; Lammers LA; van Leeuwen BL; Meijerink WJ; Nienhuijs SW; Pon J; Radema SA; van Ramshorst B; Snaebjornsson P; Tuynman JB; Te Velde EA; Wiezer MJ; de Wilt JH; Tanis PJ
    BMC Cancer; 2015 May; 15():428. PubMed ID: 26003804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
    Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
    Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of prophylactic hyperthermic intraperitoneal chemotherapy in the management of serosal involved gastric cancer.
    Saladino E; Fleres F; Mazzeo C; Pruiti V; Scollica M; Rossitto M; Cucinotta E; Macrì A
    Anticancer Res; 2014 Apr; 34(4):2019-22. PubMed ID: 24692741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.